BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wouters Y, Oosterbos J, Reynaert N, Penders J. Alarmed by misleading interference in free T3 and free T4 assays: a new case of anti-streptavidin antibodies. Clin Chem Lab Med 2020;58:e69-71. [PMID: 31605576 DOI: 10.1515/cclm-2019-0845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 D'Aurizio F, Kratzsch J, Gruson D, Petranović Ovčariček P, Giovanella L. Free thyroxine measurement in clinical practice: how to optimize indications, analytical procedures, and interpretation criteria while waiting for global standardization. Crit Rev Clin Lab Sci 2023;60:101-40. [PMID: 36227760 DOI: 10.1080/10408363.2022.2121960] [Reference Citation Analysis]
2 Ishikawa T, Sakai H, Itaya T, Hirotsugu S, Shikuma J, Miwa T, Suzuki R, Odawara M. Falsely diagnosed thyrotoxicosis caused by anti-streptavidin antibodies and pre-wash procedures. Thyroid Res 2021;14:17. [PMID: 34246285 DOI: 10.1186/s13044-021-00108-y] [Reference Citation Analysis]
3 Dahll LK, Haave EM, Dahl SR, Aas FE, Thorsby PM. Endogenous anti-streptavidin antibodies causing erroneous laboratory results more common than anticipated. Scandinavian Journal of Clinical and Laboratory Investigation 2021;81:92-103. [DOI: 10.1080/00365513.2020.1858493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]